Related Experiment Video
Updated: Jun 5, 2025
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
09:34
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.3K
T-cell-based therapies for treating relapsed or refractory mantle cell lymphoma
Zachary D Epstein-Peterson1,2, M Lia Palomba1,2
1Lymphoma Service, Division of Hematologic Malignancies, New York, NY.
Hematology. American Society of Hematology. Education Program
|December 7, 2024
Summary
New immune-based therapies show promise for mantle cell lymphoma (MCL) patients who do not respond to targeted treatments. This review explores their role in clinical practice and future research directions for improved outcomes.
Area of Science:
- Hematology
- Oncology
- Immunotherapy
Background:
- Targeted therapies like Bruton's tyrosine kinase (BTK) and BCL2 inhibitors have advanced mantle cell lymphoma (MCL) treatment.
- However, not all patients respond, and responses can be short-lived, particularly in high-risk MCL.
- Disease progression leads to shorter response times and limited survival.
Purpose of the Study:
- To review the current landscape of novel immune-based therapies for MCL.
- To examine approaches for integrating these agents into clinical practice.
- To identify unanswered questions crucial for improving patient outcomes.
Main Methods:
- Review of current literature on immune-based therapies for MCL.
- Discussion of clinical implementation strategies.
- Identification of key research questions.
Main Results:
- Mantle cell lymphoma (MCL) shows sensitivity to novel immune-based therapies.
- Chimeric antigen receptor (CAR)-T cells and bispecific T-cell engagers are emerging treatments.
- Favorable results are being observed, with these agents being investigated and implemented.
Conclusions:
- Immune-based therapies represent a significant advancement in MCL treatment.
- Further research is needed to optimize the use of these agents in routine practice.
- Addressing critical questions will enhance therapeutic strategies and patient survival in MCL.
Related Concept Videos
01:27Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:22T Cell Activation and Clonal Selection
658
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
658
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
01:27Cytotoxic T Cells-mediated Immune Response
846
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
846